A nurse prepares a dose of a trial HIV vaccine as part of the PrEPVacc study in Masaka, Uganda on March 17, 2022. (Luke Dray/Getty Images/FILE)


DISCLAIMER: The Views, Comments, Opinions, Contributions and Statements made by Readers and Contributors on this platform do not necessarily represent the views or policy of Multimedia Group Limited.